We investigated the effects ofpseudorabies virus (PRV), herpes simplex virus type 1 (HSV-1), and equineherpesvirus type 1 (EHV-1) ICP4 homologues on feline immunodeficiency virus (FIV) long terminal repeat (LTR)-directed gene expression. This was done by using the transient expression chloramphenicol acetyltransferase (CAT) assay in Crandell feline kidney (CRFK) and Felis catus whole fetus 4 cells transfected with a chimeric FIV LTR-CAT reporter construct in combination with effector plasmids expressing the PRV, HSV-1 or EHV-1 ICP4 homologue. The experiments demonstrated that the ICP4 homologues could significantly inhibit FIV LTR-directed gene expression. Moreover, the ICP4 homologues also exhibited a marked inhibitory effect on FIV replication in CRFK cells cotransfected with an infectious molecular clone of FIV.
Herpesviruses and retroviruses are associated with a variety of diseases in humans and animals (Weiss et al., 1984; Fields & Knipe, 1991) . A great deal of effort has been invested into examining a potential interaction between herpesviruses and retroviruses; it is suspected that the interaction may result in the synergistic induction of diseases (Laurence, 1990; Evermann et al., 1991) . Human herpesviruses have been implicated as potential cofactors for the development of AIDS, as the viruses are ubiquitous pathogens that are associated with increased morbidity and mortality in patients with AIDS (Macher et al., 1983; Colebunders et al., 1988) and are particularly prevalent in certain high-risk populations of AIDS patients (Quinn et al., 1987; Holmberg et al., 1988) . Co-infection of chickens with a herpesvirus (Marek's disease virus) and a retrovirus (avian leukosis virus) increased the incidence of retrovirus-associated tumours (Bacon et al., 1989) . The ability of herpesviruses in vitro to stimulate retrovirus replication and to activate long terminal repeat (LTR)-directed viral gene expression, also support the hypothesis of potential interaction between retroviruses and herpesviruses (Laurence, 1990; Evermann et al., 1991) . A number of studies concerning the molecular mechanisms of these interactions have been reported (Laurence, 1990; Evermann et al., 1991) . Although the mechanisms are not completely understood, it appears that herpesvirus gene products, mainly those of the immediate early (IE) gene, may be involved in the trans-activation of retrovirus LTRs via cellular factors (Laurence, 1990; Evermann et al., 1991) .
Feline immunodeficiency virus (FIV) belongs to the genus Lentivirus of the family Retroviridae and is associated with AIDS-like diseases in cats (Pedersen et al., 1987; Matsumura et al., 1993; Miyazawa & Mikami, 1993) . Like the other retroviruses, FIV LTR-directed gene expression could be also activated in vitro by feline herpesvirus type 1 (FHV-1) (Kawaguchi et al., 1991) which is a member of the alphaherpesvirus subfamily of the family Herpesviridae (Roizman et al., 1981) , and the sequence between positions -63 and -23 (relative to the cap site) of the FIV LTR responds to activation by FHV-1 . Among the IE genes of herpesviruses, ICP4 homologues of alphaherpesviruses are known to trans-activate a variety of heterologous promoters including retrovirus LTRs (Smiley et al., 1991) . Therefore, we are interested in the effects of regulatory properties of ICP4 homologues on FIV gene expression.
Although activation of retrovirus LTRs by the herpesvirus IE proteins appears to be a common theme, as described above, little is known about negative regulation of retrovirus gene expression by the IE proteins. In the present study, we investigated the effects ofICP4 homologues of three alphaherpesviruses, pseudorabies virus (PRV), equine herpesvirus type 1 (EHV-1), and herpes simplex virus type 1 (HSV-1), on FIV LTRdirected gene expression and FIV replication. The results show that the ICP4 homologues significantly inhibit both FIV LTR-directed gene expression and FIV replication.
Short communication

Crandell feline kidney (CRFK) cells (ATCC CCL94)
and Fells catus whole fetus 4 (fcwf-4) cells (Jacobse-Geels & Horzinek, 1983) were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 % fetal calf serum and antibiotics.
To investigate the effects of ICP4 homologues on FIV LTR-directed gene expression, the various reporter and effector plasmids were constructed and transient expression assays were performed. The LTR of FIV was inserted upstream of the bacterial chloramphenicol acetyltransferase (CAT) gene and designated as pTM1 CAT (Kawaguchi et al., 1991) . pill CAT which contains the CAT gene under control of the human immunodeficiency virus type 1 (HIV-1) LTR has been described . The construction of pCMV CAT which contains the human cytomegalovirus (HCMV) IE promoter was as described by Norimine et aL (1992) . The parent plasmid for promoters linked to the CAT gene construct was pHd CAT, which contains the CAT gene together with the simian virus 40 small t intron and polyadenylation signal . pPRIE CAT (Fig. 1 a) was constructed by inserting a 0.63 kbp NheI-BamHI subfragment (containing the PRV IE promoter/enhancer) of piE (Ihara et al., 1983) into pHd CAT. pRVPRIE ( Fig. 1 a) was constructed by insertion of a 4.8 kbp BamHI subfragment of piE, containing an entire open reading frame (ORF) of the PRV IE gene into pRVSV which contains the strong constitutive promoter cassette of the Rous sarcoma virus LTR . To construct pRVICP4 (Fig. I b) , pUK153 (a kind gift from Dr K. Umene, Kyushu University, Fukuoka, Japan) was used. The plasmid contains a 9"5 kbp EcoRI fragment obtained from the DNA of defective interfering (DI) particles of the Patton strain of HSV-1, composed of the EcoRI K fragment and a part of the EcoRI H fragment without any deletion (Umene, 1985) , and cloned into pBR325. A SalI subfragment of approximately 5"5 kbp (containing the entire ORF of the ICP4 gene) of pUK153 was cloned into pRVSV and designated pRVICP4. To construct pICP4CAT (Fig. 1 b) , a XhoI-EcoRI subfragment of pUK153, of approximately 1.4 kbp, was cloned into pBluescript KS +, and then a 0.1 kbp EcoRI-BamHI subfragment of pUK153 was inserted into EcoRI and BamHI sites of the plasmid, and designated pICP4 prom. The nucleotide sequence around the ligated EcoRI site was confirmed by sequencing, pICP4prom contains a 1.5kbp XhoIBamHI subfragment of pUK153 that has the HSV-1 ICP4 promoter. A KpnI-BamHI fragment of pICP4 prom was cloned into pHd CAT and designated pICP4 CAT. For construction of pRVEHIIE (Fig. l c) , a NheI-SacI subfragment of pEh-U2, approximately 3.0 kbp (a kind gift from Dr R. Kirisawa, Rakuno Gakuen University, Hokkaido, Japan) containing the (Kirisawa et al., 1993) and the position of the BamHI Q and S fragments containing the promoter sequence and the ORF of the EHV-1 IE gene. Construction of all the plasmids is described in the text. Abbreviations for the restriction endonuclease sites: B, BamHI; D, DraI; E, EcoRI; H, HindIII; Hc, HincII; Nh, NheI; S1, Sall; Xh, XhoI.
BamHI Q(R) fragment of the genome of EHV-1 strain HH1 cloned into pUC18 (Kirisawa et al., 1993) was deleted by treatment with T4 DNA polymerase for blunt-ending and T4 DNA ligase and designated pAEh- * Determined by comparison of the CAT activity associated with the target plasmid in the presence of the indicated effector plasmid versus that in the presence of pRVSV. U2. A 3.5 kbp BamHI-DraI subfragment of pEh-U9 (a kind gift from Dr R. Kirisawa, Rakuno Gakuen University, Hokkaido, Japan) which contains the BamHI S fragment of the genome of EHV-1 strain HH1 cloned into pUC18 (Kirisawa et al., 1993) was introduced into the XbaI (the XbaI-cut ends were blunted by treatment of T4 DNA polymerase) and BamHI sites of pAEh-U2 and designated pEHIlE. The nucleotide sequence around the ligated BamHI site was confirmed by sequencing. A 4.8 kbp EcoRI-XbaI fragment (containing the entire ORF of the EHV-1 IE gene) ofpEHllE was inserted into pRVSV and designated pRVEH 11E. pEH 11E CAT (Fig.  1 c) was generated by inserting a 0.9 kbp HinclI-HindlII subfragment (containing the promoter of the EHV-1 IE gene) of pEh-U2 into pHd CAT.
For transfection of plasmid DNAs, cells were plated in 6-well plastic microplates. Plasmid DNAs were transfected by the calcium phosphate method (Graham & van der Eb, 1973) . At 4 h after transfection, the cells were washed with DMEM and glycerol-shocked, and then fresh medium was added. Amounts of reporter plasmids transfected are indicated in Tables 1 and 2 . Effector plasmids were transfected in equimolar amounts (0"9 pmol). The final amount of DNA applied per transfection was adjusted to an equal amount by the addition of pUC19. At 72h after transfection, cell monolayers were harvested for the CAT assay. Cell extracts were prepared as described previously (Gorman et al., 1982) . CAT activity was assayed by the solvent partition method as described previously (Neumann et al., 1987) and was presented as the net d.p.m, of products formed per hour.
First, to test the functional integrity of the gene products expressed by the plasmid constructs described above, the HSV-1 ICP4, PRV IE, or EHV-1 IE gene expression vector was cotransfected into CRFK cells with its respective promoter-CAT construct. As shown in Table 1 , these ICP4 homologues could autoregulate their own promoters in a negative fashion as described previously (Virek et al., 1990; Smiley et al., 1991 ; Smith et al., 1992) , indicating that the effector plasmids were Amounts of pTM219 and effector plasmids transfected were 3 gg and 0.9 pmol, respectively. The final amount of DNA applied per transfection was adjusted to an equal amount by addition of pUC19. Supernatant fluid was collected and replaced at indicated times, and RT activity was assayed as described previously (Ohta et al., 1988) .
constructed correctly and that the ICP4 homologues could function in the feline cell line. Expression of the ICP4 homologues did not affect viability or replication rate of the cells (unpublished data).
Next, the ICP4 homologue expression vectors were cotransfected into CRFK or fcwf-4 cells with the FIV LTR-CAT, HIV-1 LTR-CAT or CMV IE promoter-CAT construct. Table 2 shows that FIV LTR-directed gene expression was significantly inhibited by the expression of the PRV, HSV-1 or EHV-1 ICP4 homologues, but that the expression of HIV-I LTR-directed and HCMV IE promoter-directed genes were not affected in CRFK cells. In fcwf-4 cells, the ICP4 homologues also had inhibitory effects on FIV LTR-directed gene expression.
To determine whether the inhibitory effects of the ICP4 homologues on the FIV LTR construct affect the replication of FIV, an infectious molecular clone of FIV (pTM219; Kiyomasu et al., 1991) was cotransfected into CRFK cells with the ICP4 homologue expression vectors (pRVPRIE and pRVEHIIE). FIV production was monitored by measuring reverse transcriptase (RT) activities of the culture supernatants from the transfected cells. RT activity was assayed as described previously (Ohta et al., 1988) . As shown in Fig. 2 , RT activity of the culture supernatants from the cells transfected with pRVSV was detectable beginning at 1 day posttransfection (p.t.), reached the maximum at 3 days p.t. and then decreased gradually. In contrast, RT activities of the culture supernatants from the cells expressing the PRV or EHV-1 ICP4 homologue were almost at background level. At 3 days p.t., the values of RT activity from the cell cultures transfected with pRVSV, pRVPRIE, and pRVEHIIE, and mock-transfected, were 67733, 2013, 2517 and 1645 c.p.m., respectively. These results indicate that the ICP4 homologues had inhibitory effects on FIV replication.
Although positive regulation of heterologous promoters by ICP4 homologues of alphaherpesviruses has been well established, less is known of the mechanisms of negative regulation of heterologous promoters by the ICP4 proteins. Thus, it is noteworthy and interesting that the HSV-1, PRV and EHV-1 ICP4 homologues mediate such a dramatic inhibition of FIV gene expression and replication (Table 2 and Fig. 2) . The mechanism of the antiviral effect of the ICP4 homologues on FIV in feline cell lines is not known at present. However it is of interest that the FIV LTR contains a sequence, ATGCTAGC-AGCT, located between positions -109 and -98 (relative to the cap site) that shares extensive identity with an ICP4-binding site (ATCGTAGCACTT, 67 % identity) in the PRV ICP4 promoter (Wu & Wilcox, 1991) and also shares homology with the ICP4-binding sites in the ICP4 promoters of HSV-1 and EHV-1 (Faber & Wilcox, 1986; Smith et al., 1992) . In addition, there are putative regulatory sequences recognized by transcription factors, such as AP-1 and C/EBP, which are known to act as both positive and negative regulators (Mermod et al., 1988; Pei & Shih, 1990) . There is a possibility that the ICP4 homologues directly or indirectly influence gene expression of the FIV LTR via these sequences. Further experiments that address the mechanisms of this negative regulation are needed and are currently underway. These will provide insight into a possible basis for anti-lentivirus therapy and also help to clarify functions of the ICP4s. The understanding of these mechanisms may also provide insight into the regulation of gene expression and pathogenesis for both lentiviruses and herpesviruses.
